Michael A Rogawski

12PUBLICATIONS
29CO-AUTHORS
Characterisation of biological macromoleculesIndustrial and organisational psychology (incl. human factors)Toxicology (incl. clinical toxicology)AllergyFood properties (incl. characteristics and health benefits)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Mar 15, 2025
ENX-101, a GABAA receptor α2,3,5-selective positive allosteric modulator, displays antiseizure effects in rodent seizure and epilepsy models.

Jordi Serrats, Krishna C Vadodaria, William Brubaker

|Mar 07, 2025
Interim analysis of the long-term efficacy and safety of azetukalner in an ongoing open-label extension study following a phase 2b clinical trial (X-TOLE) in adults with focal epilepsy.

Jacqueline A French, Roger J Porter, Emilio Perucca

|Mar 01, 2025
Allopregnanolone as an Adjunct Therapy to Midazolam is More Effective Than Midazolam Alone in Suppressing Soman-Induced Status Epilepticus in Male Rats.

Peter M Andrew, Jeremy A MacMahon, Xiuzhen Liu

|Mar 15, 2023
Tolerability and pharmacokinetics of intravenous allopregnanolone with and without midazolam pretreatment in two healthy dogs.

Donald A Bruun, Betty Ma, Yi-Je Chen

|Nov 22, 2022
A randomized, open-label, two-treatment crossover study to evaluate the effect of food on the pharmacokinetics of diazepam nasal spray in healthy adults.

Michael A Rogawski, Gary Slatko

|Apr 29, 2021
Perampanel, a potent AMPA receptor antagonist, protects against tetramethylenedisulfotetramine-induced seizures and lethality in mice: comparison with diazepam.

Dorota Zolkowska, Ashish Dhir, Michael A Rogawski

Pageof 2

Frequent Collaborators

2 joint publications

Martin J Brodie

2 joint publications

Pamela J Lein

1 joint publications

Christophe Bernard

1 joint publications

Ingmar Blümcke